Doerfler Douglas
SEC CIK 1874482 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | Pres, CEO, Dir | 358.2K | — | $5.54M | 22 | 2021-11-12 | 2023-12-04 |
Most active insiders at MXCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Swirsky Douglas J | CFO | — | $8,316 |
| 2 | Ahuja Parmeet | CFO | — | — |
| 3 | Johnston John Joseph | Dir | — | — |
| 4 | Masoud Maher | Pres, CEO, Dir | — | — |
| 5 | Hemrajani Rekha | Dir | — | — |
| 6 | Al-Wakeel Yasir B. | Dir | — | — |
| 7 | Brooke William W | Dir | — | — |
| 8 | Collins Cynthia | Dir | — | — |
| 9 | Erck Stanley C | Dir | — | — |
| 10 | BALTHROP PATRICK J | Dir | — | — |
Doerfler Douglas made no open-market trades at MXCT in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-06 | 2023-12-04+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +124.5K | 358.2K | +53% | +$4,978 |
| DM | 2023-12-06 | 2023-12-04+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.14 | -124.5K | 333.2K | -27% | -$639.4K |
| DM | 2023-12-01 | 2023-11-29+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.00 | -25.6K | 333.2K | -7% | -$127.8K |
| DM | 2023-12-01 | 2023-11-29+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +25.6K | 338.5K | +8% | +$1,022 |
| DM | 2023-07-12 | 2023-07-10+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.03 | -30.0K | 333.2K | -8% | -$150.9K |
| DM | 2023-07-12 | 2023-07-10+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +30.0K | 346.0K | +9% | +$1,200 |
| DM | 2023-06-15 | 2023-06-13+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.04 | -43.9K | 333.2K | -12% | -$220.9K |
| DM | 2023-06-15 | 2023-06-13+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +43.9K | 348.2K | +14% | +$1,754 |
| D | 2023-05-05 | 2023-05-03 | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +16.1K | 349.3K | +5% | +$645.96 |
| D | 2023-05-05 | 2023-05-03 | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.02 | -16.1K | 333.2K | -5% | -$81.1K |
| DM | 2023-04-12 | 2023-04-10+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.00 | -15.0K | 333.2K | -4% | -$75.0K |
| DM | 2023-04-12 | 2023-04-10+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +15.0K | 333.3K | +5% | +$600 |
| DM | 2023-04-07 | 2023-04-05+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.02 | -34.8K | 333.2K | -9% | -$175.0K |
| DM | 2023-04-07 | 2023-04-05+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +34.8K | 340.2K | +11% | +$1,393 |
| DM | 2023-04-04 | 2023-03-31+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.02 | -10.2K | 333.2K | -3% | -$51.1K |
| DM | 2023-04-04 | 2023-03-31+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +10.2K | 333.3K | +3% | +$407.08 |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +30.0K | 343.9K | +10% | +$1,200 |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.72 | -30.0K | 333.2K | -8% | -$171.6K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $5.08 | -30.0K | 333.2K | -8% | -$152.4K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +30.0K | 343.8K | +10% | +$1,200 |
| DM | 2021-11-16 | 2021-11-12+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | S - Sale+OE | $12.31 | -300.0K | 333.2K | -47% | -$3.69M |
| DM | 2021-11-16 | 2021-11-12+ | MXCT | MAXCYTE, INC. | Doerfler Douglas | Pres, CEO, Dir | M - OptEx | $0.04 | +200.0K | 408.1K | +96% | +$8,000 |
Purchase Sale Sale after option exercise All abbreviations